Westlake Chemical Partners LP WLKP

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases

Management's Discussion and Analysis of Financial Condition and Results of Operations

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Last close 21.15 2026-10-23
Market cap $745.5M 2026-06-30 share count
52-week range 17.75 - 23.88

Valuation FY2025 figures against the last close

P/S0.6x
P/E—
P/FCF3.7x
EV/EBITDA1.7x
Dividend yield—
Diluted EPS—

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.17B$1.14B$1.19B$1.59B$1.21B$78.4M$154.2M$1.29B$1.17B$986.7M
Cost of revenue $818.8M$717.0M$803.3M$1.22B$773.2M$587.8M$712.4M$908.5M$769.3M$595.4M
Gross profit $347.8M$418.9M$387.5M$377.4M$441.7M$378.9M$379.4M$377.2M$403.7M$391.3M
SG&A $28.3M$28.5M$29.8M$29.7M$31.0M$25.9M$29.3M$27.6M$29.3M$24.9M
Operating income $319.6M$390.4M$357.7M$347.7M$410.7M$353.0M$350.1M$349.6M$374.4M$366.4M
Interest expense $22.9M$25.7M$26.5M$13.4M——————
Pre-tax income $299.1M$370.0M$335.4M$335.8M$401.9M$341.7M$333.6M$330.6M$354.3M$354.4M
Income tax $547.0K$835.0K$813.0K$1.0M$549.0K$564.0K$728.0K$22.0K$1.3M$1.0M
Net income $48.7M$62.4M$54.3M$64.2M$82.5M$66.2M$61.0M$49.3M$48.7M$40.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $44.3M$58.3M$58.6M$64.8M$17.1M$17.2M$19.9M$19.7M$27.0M$88.9M
Receivables $9.1M$11.6M$18.7M$20.0M$5.8M$11.0M$9.9M$16.4M$18.1M$12.1M
Inventory $2.8M$4.1M$4.4M$4.7M$8.9M$3.5M$2.5M$4.4M$5.6M$3.9M
Total current assets $143.5M$240.9M$226.2M$245.8M$281.2M$263.3M$238.4M$247.1M$231.4M$232.2M
Property, plant and equipment $886.0M$903.6M$943.8M$990.2M$1.04B$1.05B$1.10B$1.15B$1.20B$1.22B
Goodwill $5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M$5.8M
Total assets $1.26B$1.29B$1.32B$1.37B$1.48B$1.36B$1.39B$1.46B$1.52B$1.56B
Accounts payable ———$15.3M$35.1M$13.1M$6.1M$5.0M$10.5M$9.9M
Total current liabilities $51.3M$55.4M$56.3M$66.9M$106.8M$39.8M$38.8M$48.8M$40.2M$37.8M
Total liabilities $454.2M$458.6M$460.6M$468.3M$508.0M$441.4M$441.3M$528.0M$516.5M$634.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $280.5M$485.0M$452.0M$463.7M$408.4M$373.4M$450.8M$436.2M$537.4M$287.7M
Depreciation and amortisation $128.0M$111.9M$110.2M$121.1M$108.8M$103.2M$107.3M$108.8M$114.0M$98.2M
Capital expenditure $78.8M$49.0M$46.8M$54.1M$81.2M$37.0M$43.7M$39.9M$68.9M$299.6M
Investing cash flow $31.2M-$89.0M-$75.9M-$12.0M-$64.3M$2.0M-$57.7M-$51.8M-$203.2M-$299.5M
Financing cash flow -$325.7M-$396.3M-$382.2M-$404.0M-$344.2M-$378.2M-$392.9M-$391.6M-$396.0M-$68.9M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001604665-26-000010.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 500M 1B 1.5B 2B Revenue, FY2016: 986.7M Gross profit, FY2016: 391.3M Net income, FY2016: 40.9M Revenue, FY2017: 1.2B Gross profit, FY2017: 403.7M Net income, FY2017: 48.7M Revenue, FY2018: 1.3B Gross profit, FY2018: 377.2M Net income, FY2018: 49.3M Revenue, FY2019: 154.2M Gross profit, FY2019: 379.4M Net income, FY2019: 61M Revenue, FY2020: 78.4M Gross profit, FY2020: 378.9M Net income, FY2020: 66.2M Revenue, FY2021: 1.2B Gross profit, FY2021: 441.7M Net income, FY2021: 82.5M Revenue, FY2022: 1.6B Gross profit, FY2022: 377.4M Net income, FY2022: 64.2M Revenue, FY2023: 1.2B Gross profit, FY2023: 387.5M Net income, FY2023: 54.3M Revenue, FY2024: 1.1B Gross profit, FY2024: 418.9M Net income, FY2024: 62.4M Revenue, FY2025: 1.2B Gross profit, FY2025: 347.8M Net income, FY2025: 48.7M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $986.7M $1.17B $1.29B $154.2M $78.4M $1.21B $1.59B $1.19B $1.14B $1.17B
Gross profit $391.3M $403.7M $377.2M $379.4M $378.9M $441.7M $377.4M $387.5M $418.9M $347.8M
Net income $40.9M $48.7M $49.3M $61.0M $66.2M $82.5M $64.2M $54.3M $62.4M $48.7M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
GEVO Gevo, Inc. $286.8M — 849.3%